Takeda Sues Watson Over Sleeping Pill ANDA
The complaint, filed Wednesday in the U.S. District Court for the District of Delaware, alleges Watson is seeking regulatory approval to manufacture and sell a treatment for insomnia that infringes Takeda’s patent rights.
Last month the defendant notified Takeda that it had submitted an abbreviated new drug application with the U.S. Food and Drug...
Already a subscriber? Click here to login